Nobody likes to think of this, but would your family be provided for if you die?
We’re not selling life insurance or estate planning, but accidents happen, and it is easy to put off prudent preparations when you are young and healthy.
The graph below shows an increase in all-cause death (blue bars) in persons age 15–44 and in cancer deaths (red bars) in 2020–2022. If these numbers are real (and “excess deaths” may be hard to define), they are cause for serious concern.
Cancer is supposed to be primarily a disease of aging. But physicians, including oncologists, are reporting “anecdotally” that they are seeing more cases of rare, unusually aggressive cancers in younger persons. Is this happenstance? An impression fostered by sensational reporting and retweeting on social media of a few unfortunate but unusual cases? Or is even one case a possible “canary in a coal mine”?
What happened in 2020–2022? The COVID pandemic was receding, but can the SARS-CoV-2 virus cause rapid development of cancer after a year or so? Various suspects are in the news. But microplastics, ultraprocessed foods, forever chemicals, and other concerns of the MAHA movement did not suddenly arise or surge.
What did arise and get injected into the majority of the population was mRNA COVID vaccines. Correlation does not prove causality, but lack of correlation disproves it. What is the vaccination history of young healthy people who unexpectedly died prematurely, especially of cancer? What are the autopsy findings? Where are the research projects investigating a possible mechanism? Is there a mention of this possibility in informed consent? The results of long-term studies could not have been known when the emergency-use product was released.
Everyone who has dependents needs to be sure they are provided for—even if average life expectancy has not changed.
Public health officials and physicians need to rigorously investigate and rule out a possible role for these novel products in causing serious disease before allowing further use, or before rushing similar products into production.
Additional Information:
